India
· Delayed Price · Currency is INR Jenburkt Pharmaceuticals Statistics
Total Valuation
BOM:524731 has a market cap or net worth of INR 4.86 billion. The enterprise value is 4.10 billion.
| Market Cap | 4.86B |
| Enterprise Value | 4.10B |
Important Dates
The next estimated earnings date is Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | Jul 23, 2024 |
Share Statistics
BOM:524731 has 4.41 million shares outstanding. The number of shares has increased by 3.09% in one year.
| Current Share Class | 4.41M |
| Shares Outstanding | 4.41M |
| Shares Change (YoY) | +3.09% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 43.84% |
| Owned by Institutions (%) | 2.57% |
| Float | 1.77M |
Valuation Ratios
The trailing PE ratio is 15.47.
| PE Ratio | 15.47 |
| Forward PE | n/a |
| PS Ratio | 3.25 |
| PB Ratio | 3.08 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.06 |
| EV / Sales | 2.74 |
| EV / EBITDA | 10.56 |
| EV / EBIT | 11.14 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | n/a |
| Interest Coverage | 102.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.85% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.99M |
| Profits Per Employee | 417,632 |
| Employee Count | 752 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.52% in the last 52 weeks. The beta is 0.43, so BOM:524731's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +36.52% |
| 50-Day Moving Average | 1,021.43 |
| 200-Day Moving Average | 1,089.81 |
| Relative Strength Index (RSI) | 59.97 |
| Average Volume (20 Days) | 1,092 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524731 had revenue of INR 1.49 billion and earned 314.06 million in profits. Earnings per share was 71.16.
| Revenue | 1.49B |
| Gross Profit | 1.19B |
| Operating Income | 368.36M |
| Pretax Income | 424.62M |
| Net Income | 314.06M |
| EBITDA | 384.26M |
| EBIT | 368.36M |
| Earnings Per Share (EPS) | 71.16 |
Balance Sheet
The company has 776.86 million in cash and 21.14 million in debt, giving a net cash position of 755.72 million or 171.24 per share.
| Cash & Cash Equivalents | 776.86M |
| Total Debt | 21.14M |
| Net Cash | 755.72M |
| Net Cash Per Share | 171.24 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 357.41 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 79.33%, with operating and profit margins of 24.64% and 21.01%.
| Gross Margin | 79.33% |
| Operating Margin | 24.64% |
| Pretax Margin | 28.41% |
| Profit Margin | 21.01% |
| EBITDA Margin | 25.71% |
| EBIT Margin | 24.64% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 15.30, which amounts to a dividend yield of 1.41%.
| Dividend Per Share | 15.30 |
| Dividend Yield | 1.41% |
| Dividend Growth (YoY) | 6.25% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | -3.09% |
| Shareholder Yield | -1.68% |
| Earnings Yield | 6.46% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |